Phase II trial of romidepsin (FK228 or depsipeptide) in peripheral T-cell lymphoma: clinical activity and molecular markers. Hematology Meeting Reports (formerly Haematologica Reports), [S. l.], v. 2, n. 13, 2009. DOI: 10.4081/hmr.v2i13.482. Disponível em: https://journals.pagepress.org/hmr/article/view/482. Acesso em: 4 jul. 2025.